Individualized Homeopathic Medicines in Treating Depression, Anxiety, and Stress in Adults with Osteoarthritis of the Knee: A Double-Blind, Randomized, Placebo-Controlled Trial
Individuelle homöopathische Arzneien zur Behandlung von Depression, Angst und Stress bei Erwachsenen mit Kniearthrose: doppelblinde, randomisierte, placebokontrollierte Studie
Homeopathy · 24.09.2026
DOI: 10.1055/a-2850-9160 ↗Auf einen Blick
Individuelle homöopathische Arzneien verbesserten in dieser Studie Depression, Angst und Stress bei Kniearthrose stärker als Placebo. Auch Schmerzen, Funktion und Lebensqualität nahmen zu.
Fragestellung
Wirksamkeit und Sicherheit individueller homöopathischer Arzneien im Vergleich zu Placebo bei Erwachsenen mit Kniearthrose und komorbider Depression, Angst und/oder Stress.
Methode
Doppelblinde, randomisierte (2:1), placebokontrollierte klinische Studie in einem Lehrkrankenhaus in Kolkata, Indien; Beurteilung monatlich über 3 Monate; multivariate lineare Mixed-Effects-Modelle.
Ergebnisse
DASS-21-Depression, Angst und Stress verbesserten sich unter IHM gegenüber Placebo signifikant (p < 0,001). Auch KOOS und WOMAC-Schmerz, Funktion und Lebensqualität verbesserten sich; Responderrate 59 % vs. 11 %.
Schlussfolgerung der Autor:innen
Individuelle homöopathische Arzneien führten im Vergleich zu Placebo zu signifikanten Verbesserungen psychischer Symptome und körperlicher Outcomes bei Kniearthrose ohne unerwünschte Ereignisse.
Kernaussagen
- Bessere DASS-21-Werte unter IHM als unter Placebo
- Auch KOOS und WOMAC verbesserten sich
- Keine unerwünschten Ereignisse berichtet
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Homeopathy, erschienen am 24.09.2026. Verfasst von Meghamala Chakraborty und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Practice of Medicine, The Calcutta Homoeopathic Medical College and Hospital, Government of West Bengal, affiliated to the West Bengal …. Die Arbeit nennt 26 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Knee osteoarthritis (OA) is frequently accompanied by depression, anxiety and stress, worsening pain, disability and quality of life. Evidence for individualized homeopathic medicines (IHMs) in addressing these co-existing psychological and physical burdens remains limited. This trial aimed to evaluate the efficacy and safety of IHMs compared with placebo in adults with knee OA and co-morbid depression, anxiety and/or stress. A double-blind, randomized (2:1), placebo-controlled, clinical trial was conducted at a teaching hospital in Kolkata, India. One hundred and ten participants aged between 50 and 70 years with knee OA (American College of Rheumatology [ACR] criteria) and mild-to-moderate depression (DASS-21) were randomized to receive IHMs plus concomitant care (CC) or placebo plus concomitant care for 3 months. Remedies were individualized through standardized homeopathic case-taking. Outcomes (DASS-21, Knee Injury and Osteoarthritis Outcome Score [KOOS], WOMAC, and Measure Yourself Medical Outcome Profile version 2 [MYMOP-2]) were assessed monthly for 3 months. Efficacy was assessed using multivariate linear mixed-effects models (primary test: Intervention × time interaction). Area under the curve analyses, effect sizes, and sensitivity analyses using Generalized Estimating Equations, and responder analyses were performed. Adjusted p-values used the Holm–Bonferroni method. A significant group-by-time interaction favored IHMs for DASS-21 depression (p < 0.001), anxiety, and stress, alongside clinically meaningful improvements in KOOS and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, function, and quality of life (most adjusted p < 0.001). Responder rates were higher with IHMs (59% vs. 11%). Mediation analysis indicated that pain reduction partially explained improvements in depression. No adverse events were reported. IHMs produced significant improvements in both psychological symptoms and physical outcomes related to knee OA compared with placebo, reflecting a holistic therapeutic effect without adverse events. CTRI/2024/03/064632.
Autor:innen und Institutionen
- Department of Practice of Medicine, The Calcutta Homoeopathic Medical College and Hospital, Government of West Bengal, affiliated to the West Bengal University of Health Sciences, Kolkata, West Bengal, India.
- Department of Repertory, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, affiliated to the West Bengal University of Health Science, Tangra, Kolkata, West Bengal, India.
- Department of Homeopathy, East Bishnupur State Homoeopathic Dispensary, Chandi Daulatabad Block Primary Health Centre, under Department of Health & Family Welfare, Government of West Bengal, West Bengal, India.
ORCID-Profile: Subhranil Saha
Zitieren
APA
Chakraborty, M., Chattapadhyay, R., Mondal, M., Bhowmick, S., Khatoon, R., Sarkar, S., Parveen, T., Sen, P., Koley, M., & Saha, S. (2026). Individualized Homeopathic Medicines in Treating Depression, Anxiety, and Stress in Adults with Osteoarthritis of the Knee: A Double-Blind, Randomized, Placebo-Controlled Trial. Homeopathy. https://doi.org/10.1055/a-2850-9160
Vancouver
Chakraborty M, Chattapadhyay R, Mondal M, Bhowmick S, Khatoon R, Sarkar S, et al. Individualized Homeopathic Medicines in Treating Depression, Anxiety, and Stress in Adults with Osteoarthritis of the Knee: A Double-Blind, Randomized, Placebo-Controlled Trial. Homeopathy. 2026. doi:10.1055/a-2850-9160
BibTeX
@article{Chakraborty2026,
author = {Chakraborty, Meghamala and Chattapadhyay, Rajat and Mondal, Madhushree and Bhowmick, Sayantan and Khatoon, Rayba and Sarkar, Sanjay and Parveen, Tuhina and Sen, Priyanka and Koley, Munmun and Saha, Subhranil},
title = {Individualized Homeopathic Medicines in Treating Depression, Anxiety, and Stress in Adults with Osteoarthritis of the Knee: A Double-Blind, Randomized, Placebo-Controlled Trial},
journal = {Homeopathy},
year = {2026},
doi = {10.1055/a-2850-9160}
}
EUVIMED